Hormone Facts > Melanocyte Stimulating Hormone

Please select a hormone news story from our table of contents below:


New insight into the response of human skin to radiation

Friday 21st of November 2008, 2:02 pm

Scientists have new insight into the response of human skin to radiation and what drives the most aggressive and deadly form of skin cancer.

Survival Of Melanoma Cells Promoted By Gene Required For Radiation-Induced Protective Pigmentation

Friday 21st of November 2008, 6:09 am

Scientists have new insight into the response of human skin to radiation and what drives the most aggressive and deadly form of skin cancer. The research, published by Cell Press in the November 21st issue of the journal Molecular Cell, may be useful in the design of new strategies for prevention of malignant melanoma.

Gene required for radiation-induced protective pigmentation also promotes survival of melanoma cells

Thursday 20th of November 2008, 9:26 am

( Cell Press ) Scientists have new insight into the response of human skin to radiation and what drives the most aggressive and deadly form of skin cancer. The research, published by Cell Press in the Nov. 21 issue of the journal Molecular Cell, may be useful in the design of new strategies for prevention of malignant melanoma.

How To Restore Colour To White Hair Following Illness - British Association Of Dermatologists

Friday 14th of November 2008, 5:07 am

Scientists have discovered a way to potentially restore colour to white hair, new research in the British Journal of Dermatology will reveal this month. A number of skin disorders cause the hair to fall out, and when it re-grows, it is often white. For many patients, this is almost as distressing as the initial hair loss.

New research finds way to restore colour to white hair following illness

Thursday 13th of November 2008, 1:17 pm

(PhysOrg.com) -- Scientists have discovered a way to potentially restore colour to white hair, new research in the British Journal of Dermatology reveals this month.

My Pharmiweb.com

Friday 7th of November 2008, 2:55 am

Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, today announced preclinical data on a novel generation of melanocortin-4 (MC4) receptor antagonists for potential treatment of cancer cachexia (severe muscle wasting).


Industry Term

Technology Term


Powered by Odin Assemble